We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Technology Differentiates Five Entamoeba Species

By LabMedica International staff writers
Posted on 06 Jun 2013
A rapid, high-throughput screening method has been developed for the simultaneous detection and differentiation of Entamoeba species.

Among the Entamoeba species, only E. More...
histolytica is considered to be pathogenic, causing intestinal and extraintestinal disease, but it is morphologically identical to E. dispar and E. moshkovskii.

Scientists at The Federal University of Rio de Janeiro (Brazil) extracted 74 DNA samples from human stools and nine of these DNA extracts were from stools that were positive for Entamoeba species by microscopy. Polymerase chain reaction (PCR) amplification was performed with biotinylated Entamoeba spp 18S ribosomal ribonucleic acid (rRNA) gene primers, designed to amplify a fragment ranging from 382 to 429 base pairs (bp) of the Entamoeba species studied.

All parasitological positive samples were tested using real-time PCR and nine stools samples were also analyzed by DNA sequencing. In addition regions of the fragments that could differentiate among E. histolytica, E. moshkovskii, E. dispar, E. hartmanii and E. coli were selected to design hybridization probes to link to Luminex beads (Austin, TX, USA). The assay was standardized with cloned DNA samples of each species and evaluated with 24 DNA extracts from samples obtained from individuals diagnosed with these amebae in their stools.

The investigators were able to correctly identify the five different species in all of the specimens studied. From the 24 samples tested by microscopy, PCR/DNA Sequencing and real-time PCR, there was 100% concordance with the PCR-Luminex assay for identification of E. dispar, E. moshkovskii, E. hartmanni, E. histolytica, and E. coli. They were able to identify samples with more than one species of Entamoeba by performing a Luminex assay and all fifty parasitologically negative stool samples were negative in the assay.

The authors concluded that that the method could be used in the diagnostic detection of Entamoeba species in fecal samples. This diagnostic test was useful to clearly distinguish the pathogenic E. histolytica from the other species and also to strengthen epidemiologic data on Entamoeba species. The study was published on March 15, 2013, in the journal Parasites & Vectors.

Related Links:

The Federal University of Rio de Janeiro

Luminex


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Neuron-derived extracellular vesicles carry many biomarker candidates for Alzheimer’s (S Chinnathambi et al., Brain Network Disorders (2025). doi.org/10.1016/j.bnd.2024.12.006)

Neuron-Derived Extracellular Vesicles Could Improve Alzheimer’s Diagnosis

Alzheimer’s disease is becoming increasingly common as global populations age, yet effective treatments for advanced stages remain limited. Early detection is therefore critical, but current diagnostic... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.